Načítá se...
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
BACKGROUND: Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co‐ordination and unsteadiness. These adverse events often occur during peaks in drug plasma concentration. These adverse event...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2016
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463840/ https://ncbi.nlm.nih.gov/pubmed/27933615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007124.pub5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|